| Article
In a recent press release, the marketing research and strategic planning firm Pain Insights, Inc., announced the publication of a new study of patient views on the use of opioids, nonopioid analgesics, and nonpharmacologic therapies for the management of chronic pain. The study was undertaken to...
| Article
A new consensus report released last week by a panel of the National Academies of Sciences, Engineering, and Medicine urges a broad-based rethinking of our approach to chronic pain management, which would require changes in outlook and behavior from all stakeholders, including clinicians, patients...
| Article
A report published earlier this year in Journal of Opioid Management concludes that handwritten prescriptions for opioids are significantly more error-prone than are electronically created orders for the medications. Researchers conducted a small study of opioid prescriptions filled at the...
| Article
The Federation of State Medical Boards (FSMB) recently released an updated version of its guidelines for prescribers in the use of opioid therapy for chronic pain. The revised document draws on recent advisories from the CDC and the FDA, and is intended to reflect the most current science for...
| Article
A review of available research conducted by a team from Erasmus University Medical Center in Rotterdam, the Netherlands has identified 10 genes that may help prescribers to anticipate individual patient responses to opioid therapy. The genetic markers could thus be of value to providers in adjusting...
| Article
Findings from a study conducted by researchers at Stanford University School of Medicine, Palo Alto, highlight the significance of pain catastrophizing as a predictor of opioid prescribing patterns for women with chronic pain. The study found that female patients who catastrophize both report higher...
| Video
At PAINWeek 2016, a panel of medical, legal, and pharmacy specialists convened to offer their views on the recently introduced prescribing guidelines for chronic pain from the CDC. In this segment, Dr. Ziegler and Dr. Fudin summarize some of the concerns voiced over the guideline development process...
| Article
On average, patients with osteoarthritis of the knee spend 13 years taking medications before undergoing total knee arthroplasty (TKA) and almost 25% of these are prescribed opioids, according to research findings appearing this month in Journal of Bone & Joint Surgery. However, the study found that...
| Article
Researchers from the Perelman School of Medicine at the University of Pennsylvania are voicing concern over disparate opioid prescribing patterns for minor injuries and the contribution of these to the public health crisis of opioid abuse and overdose death. In an examination of patient records of...
| Article
The use of interventional procedures is probably going to increase due to the CDC guidelines, because they are emphasizing non-opioid, and non-pharmacological therapies. So this is an important area for primary care doctors to understand, specifically if we look at patients with low back pain, one...